Evidence map›Paper›PMID 34932229›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

α-Amino-iso-Butyric Acid Foldamers Terminated with Rhodium(I) N-Heterocyclic Carbene Catalysts.

David P Tilly, William Cullen, Heng Zhong, Romain Jamagne, Inigo Vitórica-Yrezábal, Simon J Webb

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. A ChiralJournal of the American Chemical Society · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David P TillyManchester Institute of Biotechnology, University of Manchester, 131 Princess St, Manchester, M1 7DN, UK.ORCID http://orcid.org/0000-0002-4859-961X
William CullenManchester Institute of Biotechnology, University of Manchester, 131 Princess St, Manchester, M1 7DN, UK.ORCID http://orcid.org/0000-0001-6540-6341
Heng ZhongManchester Institute of Biotechnology, University of Manchester, 131 Princess St, Manchester, M1 7DN, UK.ORCID http://orcid.org/0000-0002-9210-5883
Romain JamagneDepartment of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.ORCID http://orcid.org/0000-0003-0454-3435
Inigo Vitórica-YrezábalDepartment of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.ORCID http://orcid.org/0000-0001-8806-150X
Simon J WebbManchester Institute of Biotechnology, University of Manchester, 131 Princess St, Manchester, M1 7DN, UK.ORCID http://orcid.org/0000-0001-9793-8748

Funding

Engineering and Physical Sciences Research Council EP/K039547Engineering and Physical Sciences Research Council EP/P027067/1Engineering and Physical Sciences Research Council EP/S023755/1
6 · The paper itself

Abstract

To investigate how remotely induced changes in ligand folding might affect catalysis by organometallic complexes, dynamic α-amino-iso-butyric acid (Aib) peptide foldamers bearing rhodium(I) N-heterocyclic carbene (NHC) complexes have been synthesized and studied. X-ray crystallography of a foldamer with an N-terminal azide and a C-terminal Rh(NHC)(Cl)(diene) complex showed a racemate with a chiral axis in the Rh(NHC) complex and a distorted 3

Indexed as

Heterocyclic CompoundsOrganometallic CompoundsRhodiumButyric AcidCatalysisIridiumMethaneModels, MolecularMolecular StructureStereoisomerismButyric AcidcarbeneHeterocyclic CompoundsIridiumMethaneOrganometallic CompoundsRhodiumcarbene ligandsconformation analysisfoldamershomogeneous catalysisrhodium

Identifiers

PMID34932229
PMCPMC9305545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.